U

UBCare Co Ltd
KOSDAQ:032620

Watchlist Manager
UBCare Co Ltd
KOSDAQ:032620
Watchlist
Price: 3 415 KRW -4.87% Market Closed
Market Cap: 173.3B KRW
Have any thoughts about
UBCare Co Ltd?
Write Note

UBCare Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

UBCare Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
I
071200
D
315640
C
311690
L
328130
J
322510

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
U
UBCare Co Ltd
KOSDAQ:032620
Cash & Cash Equivalents
â‚©26.5B
CAGR 3-Years
-24%
CAGR 5-Years
30%
CAGR 10-Years
14%
I
Infinitt Healthcare Co Ltd
KOSDAQ:071200
Cash & Cash Equivalents
â‚©31.4B
CAGR 3-Years
-6%
CAGR 5-Years
19%
CAGR 10-Years
N/A
D
DeepNoid Inc
KOSDAQ:315640
Cash & Cash Equivalents
â‚©21.5B
CAGR 3-Years
30%
CAGR 5-Years
117%
CAGR 10-Years
N/A
C
CJ Bioscience Inc
KOSDAQ:311690
Cash & Cash Equivalents
â‚©64.1B
CAGR 3-Years
69%
CAGR 5-Years
43%
CAGR 10-Years
N/A
L
Lunit Inc
KOSDAQ:328130
Cash & Cash Equivalents
â‚©31.6B
CAGR 3-Years
54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
JLK Inc
KOSDAQ:322510
Cash & Cash Equivalents
â‚©6.1B
CAGR 3-Years
-22%
CAGR 5-Years
13%
CAGR 10-Years
N/A

See Also

What is UBCare Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
26.5B KRW

Based on the financial report for Jun 30, 2024, UBCare Co Ltd's Cash & Cash Equivalents amounts to 26.5B KRW.

What is UBCare Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
14%

Over the last year, the Cash & Cash Equivalents growth was 16%. The average annual Cash & Cash Equivalents growth rates for UBCare Co Ltd have been -24% over the past three years , 30% over the past five years , and 14% over the past ten years .

Back to Top